Metformin Hydrochloride Extended-Release Tablets 500mg and 700 mg have been marked by the U.S. Food and Drug Administration for recalls due to possible presence of carcinogens (cancer-causing substances). According to WebMD, the recalled diabetic products were manufactured by Marksans Pharma Limited along with the Sun Pharmaceutical Industries on Monday, October 5 and were found to contain nitrosamines.
The FDA is regularly researching the mysterious growth of carcinogens such as nitrosamines in diabetes medications. It is still unclear how the contaminants appeared in the medicine. Nitrosamines have also been detected in some recent batches of heartburn and blood pressure medications.
Patients using affected Metformin tablets are advised to get in touch with their doctors, but are told they should not cease taking affected tablets as this could result in diabetes-related complications.
The FDA is now requiring drug companies to have their products tested and sampled with acceptable amounts of nitrosamines before releasing full products. Long-term exposure to carcinogens is most harmful while short term exposure under the daily acceptable limit for humans is not as dangerous.
The total list if recalled products is substantial, accounting for nearly 180 unique products with various NDCs, Lot Numbers, and Expiration Dates
If you or a loved one have suffered an injury or illness due to a defective or dangerous product, contact Thomas J. Henry Law. Over two decades of experience handling a multitude of defective product cases and extensive legal and financial resources allow us to provide our clients with truly dynamic legal representation. Thomas J. Henry Law has a proven track record of achieving real results for clients devastated by recalled products.
Let us help you recover the compensation you are entitled to. Our firm has offices in Corpus Christi, San Antonio, and Austin serving clients across Texas and nationwide. Contact us today for a free case review.